Evidence map›Paper›PMID 30550822›Full record

ArticleGastroenterology2019

Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.

Daniel Triner, Samantha N Devenport, Sadeesh K Ramakrishnan, Xiaoya Ma, Ryan A Frieler, Joel K Greenson, Naohiro Inohara, Gabriel Nunez, Justin A Colacino, Richard M Mortensen and 1 more

Abstract read
In one paragraph

Article in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 167 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Daniel TrinerMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Samantha N DevenportMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Sadeesh K RamakrishnanMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Xiaoya MaMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Ryan A FrielerMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Joel K GreensonDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Naohiro InoharaDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Gabriel NunezDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan.
Justin A ColacinoDepartment of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan; Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan.
Richard M MortensenMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan; Internal Medicine Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan.
Yatrik M ShahMolecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; Internal Medicine Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: shahy@umich.edu.
University of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Norah Lynn Henry · 1988 to 2026
$178.2M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John D. Meeker · 2011 to 2026
$21.5M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
Control of iron absorption by intestinal HIF2 in iron and hematological disordersR01DK095201 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2012 to 2025
$5.7M
The role of HIF2alpha in colon carcinogenesisR01CA148828 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2010 to 2025
$5.2M
Diversity SupplementR01ES028802 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin Adam Colacino · 2018 to 2026
$4.8M
The Role of Intestinal Hypoxia Signaling in Glucose HomeostasisR00DK110537 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAMAKRISHNAN, SADEESH KUMAR · 2018 to 2020
$727k
The Role of Intestinal Hypoxia Signaling in Glucose HomeostasisK99DK110537 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAMAKRISHNAN, SADEESH KUMAR · 2016 to 2017
$179k
MAZ as a Novel Regulator of STAT3 Signaling in Colon CancerF30CA213664 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRINER, DANIEL AUGUSTUS · 2017 to 2018
$43k
NCI NIH HHS F30 CA213664NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA130810NCI NIH HHS R01 CA148828NIDDK NIH HHS K99 DK110537NIDDK NIH HHS R00 DK110537NIDDK NIH HHS R01 DK095201NIEHS NIH HHS R01 ES028802NIGMS NIH HHS T32 GM007315
6 · The paper itself

Abstract

BACKGROUND &

aimsNeutrophils are among the most prevalent immune cells in the microenvironment of colon tumors; they are believed to promote growth of colon tumors, and their numbers correlate with outcomes of patients with colon cancer. Trials of inhibitors of neutrophil trafficking are underway in patients with cancer, but it is not clear how neutrophils contribute to colon tumorigenesis.

methodsColitis-associated colon cancer was induced in mice with conditional deletion of neutrophils (LysMCre;Mcl1

resultsIn mice with inflammation-induced and sporadic colon tumors, depletion of neutrophils increased the growth, proliferation, and invasiveness of the tumors. RNA sequencing analysis identified genes that regulate antimicrobial and inflammatory processes that were dysregulated in neutrophil-deficient colon tumors compared with colon tumors from control mice. Neutrophil depletion correlated with increased numbers of bacteria in tumors and proliferation of tumor cells, tumor-cell DNA damage, and an inflammatory response mediated by interleukin 17 (IL17). The 16s ribosomal RNA sequencing identified significant differences in the composition of the microbiota between colon tumors from neutrophil-deficient vs control mice. Administration of antibiotics or a neutralizing antibody against IL17 to neutrophil-deficient mice resulted in development of less-invasive tumors compared with mice given vehicle. We found bacteria in tumors to induce production of IL17, which promotes influx of intratumor B cells that promote tumor growth and progression.

conclusionsIn comparisons of mice with vs without neutrophils, we found neutrophils to slow colon tumor growth and progression by restricting numbers of bacteria and tumor-associated inflammatory responses.

Indexed as

Cell MovementCell ProliferationAdenocarcinomaAnimalsAnti-Bacterial AgentsAntibodies, NeutralizingAzoxymethaneBacteriaCell Transformation, NeoplasticColonic NeoplasmsDextran SulfateDisease Models, AnimalDisease ProgressionFemaleHost-Pathogen InteractionsInterleukin-17Anti-Bacterial AgentsAntibodies, NeutralizingAzoxymethaneDextran SulfateInterleukin-17Antitumor Immune ResponseCytotoxicGeneticPMNs

Identifiers

PMID30550822
PMCPMC6441634
OpenAlexW2904536734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.